Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.55 USD | -7.27% | -7.34% | +3.37% |
May. 09 | RBC Cuts Price Target on IGM Biosciences to $20 From $21, Keeps Outperform, Speculative Risk | MT |
May. 08 | Earnings Flash (IGMS) IGM BIOSCIENCES Posts Q1 Collaboration Revenue $497,000 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.37% | 544M | |
+9.85% | 115B | |
+11.79% | 106B | |
-2.59% | 21.96B | |
-13.45% | 21.87B | |
-5.29% | 19.21B | |
-2.92% | 18.08B | |
-38.57% | 17.71B | |
+6.23% | 14.32B | |
+34.10% | 12.42B |
- Stock Market
- Equities
- IGMS Stock
- News IGM Biosciences, Inc.
- HC Wainwright Downgrades IGM Biosciences to Neutral From Buy, Cuts Price Target to $7 From $11